CONSTRUCTIVE BIOLOGY LIMITED

Active London

Research and experimental development on biotechnology

46 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CONSTRUCTIVE BIOLOGY LIMITED

Research and experimental development on biotechnology

Founded 22 Nov 2021 Active London, United Kingdom 46 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

CONSTRUCTIVE GENOMICS LIMITED 22 Nov 2021 — 3 Aug 2022
Accounts Submitted 16 Apr 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 26 Nov 2025 Next due 23 Nov 2026 5 months remaining
Net assets £48M £15M 2025 year on year
Total assets £50M £16M 2025 year on year
Total Liabilities £2M £928K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

27 Old Gloucester Street London WC1N 3AX United Kingdom

Website

www.example.com

Full company profile for CONSTRUCTIVE BIOLOGY LIMITED (13758641), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 22 Nov 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2022–2025)

Cash in Bank

£45.23M

Increased by £13.87M (+44%)

Net Assets

£47.99M

Increased by £14.86M (+45%)

Total Liabilities

£1.83M

Increased by £928.31k (+104%)

Turnover

£10.78M

Employees

46

Increased by 18 (+64%)

Debt Ratio

4%

Increased by 1 (+33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Aug 2022Series A, Seed
Investor 4Aug 2022Series A, Seed
Investor 7Aug 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 4,222,084 Shares £57.60m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Feb 2026884£0.001£0
26 Sept 2025807,259£15.05m£18.64
25 Sept 20252,612£0.003£0
25 Feb 20257,152£133k£18.64
10 Feb 2025567£0.001£0

Officers

Officers

3 active
Status
Aleksandra Maria WlodekDirectorPolish,britishUnited Kingdom4029 Jul 2022Active
Gregory Paul WinterDirectorBritishUnited Kingdom754 Sept 2024Active
Shyam KamadolliDirectorAmericanUnited States574 Sept 2024Active

Shareholders

Shareholders (29)

Paladin Cyber Spv Ii, Llc, Series 40
17.2%
742,489
Ahren Ii Lp, Acting Through Its General Partner, Ahren Innovation Capital Guernsey (gp) Ii Limited
8.7%
378,004

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Jason William Karl Chin

Ceased 13 May 2022

Ceased

Amadeus V Technology Gp Lp

Ceased 4 Sept 2024

Ceased
Ceased

Group Structure

Group Structure

CONSTRUCTIVE BIOLOGY LIMITED Current Company
RECODED GENOMICS LTD united kingdom

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit 4, Lion Works, Station Road, Whittlesford, Cambridge (CB22 4WL) SOUTH CAMBRIDGESHIRE
Leasehold-6 Dec 2023
Unit 4, Lion Works, Station Road, Whittlesford, Cambridge (CB22 4WL)
Leasehold
Added 6 Dec 2023
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
7 May 2026OfficersAppointment of James Barry Weissman as director on 24 Apr 2026
16 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
26 Feb 2026CapitalAllotment of shares (GBP 4.322084) on 5 Feb 2026
26 Nov 2025Confirmation StatementConfirmation statement made on 9 Nov 2025 with updates
24 Oct 2025CapitalAllotment of shares (GBP 4.3212) on 14 Oct 2025
7 May 2026 Officers

Appointment of James Barry Weissman as director on 24 Apr 2026

16 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

26 Feb 2026 Capital

Allotment of shares (GBP 4.322084) on 5 Feb 2026

26 Nov 2025 Confirmation Statement

Confirmation statement made on 9 Nov 2025 with updates

24 Oct 2025 Capital

Allotment of shares (GBP 4.3212) on 14 Oct 2025

Recent Activity

Latest Activity

Appointment of James Barry Weissman as director on 24 Apr 2026

1 months ago on 7 May 2026

Annual accounts made up to 31 Dec 2025

1 months ago on 16 Apr 2026

Allotment of shares (GBP 4.322084) on 5 Feb 2026

3 months ago on 26 Feb 2026

Confirmation statement made on 9 Nov 2025 with updates

6 months ago on 26 Nov 2025

Allotment of shares (GBP 4.3212) on 14 Oct 2025

7 months ago on 24 Oct 2025